β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis-Reference-Cited by-全球学者库

β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis

Published:2023-06 Issue: Volume:114 Page:154769
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Wu Zhixuan^ORCID,Wu Haodong,Wang Ziqiong,Li Hongfeng,Gu Hongyi,Xia Erjie,Yan Congzhi,Dai Yinwei,Liu Conghui,Wang Xiaowu,Lv Linxi,Bao Jingxia,Wang Ouchen,Dai Xuanxuan

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference27 articles.

1. Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition;Bai;Am. J. Cancer Res.,2021

2. Sacituzumab govitecan in metastatic triple-negative breast cancer;Bardia;N. Engl. J. Med.,2021

3. Network analyses in systems pharmacology;Berger;Bioinformatics,2009

4. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis;Chang;Neoplasia,2013

5. Cellular pharmacology studies of shikonin derivatives;Chen;Phytother. Res.,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease;Journal of Ethnopharmacology;2024-03

2. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model;International Journal of Molecular Sciences;2023-11-02